Has the human biological interaction with SARS‐CoV2 variants entered a pliant “Faustian bargain”?

Documenti analoghi

• An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
  di: Josef Finsterer
  Pubblicazione: (2024)
• A Unified Explanation for Drug Repurposing and Pharmacological Pleiotropy Based on Classical and Statistical Thermodynamics
  di: Richard Head, et al.
  Pubblicazione: (2025)
• Supporting Pediatric RSV Clinical Trials Through Close Epidemiological Surveillance During the SARS‐CoV‐2 Pandemic
  di: Rennie Joshi, et al.
  Pubblicazione: (2025)
• Phenotype versus genotype to optimize cancer dosing in the clinical setting—focus on 5‐fluorouracil and tyrosine kinase inhibitors
  di: Jennifer H. Martin, et al.
  Pubblicazione: (2024)
• Metabolite profiling of foslevodopa/foscarbidopa in plasma of healthy human participants by LC‐HRMS indicates no major differences compared to administration of levodopa/carbidopa intestinal gel
  di: John P. Savaryn, et al.
  Pubblicazione: (2024)